 |
인쇄하기
취소
|
Registration terms for new drugs remarkably to shorten
When the preliminary review system for the protocol of clinical studies being exercised, the new drug registration process seems to be remarkably shortened effective from 2003.
The KFDA intends to charge the review fees at 6 million won per case and at 4.5 million won for other additional information reviews regarding the new drug development background, efficacy and indications.
The pre...
The KFDA intends to charge the review fees at 6 million won per case and at 4.5 million won for other additional information reviews regarding the new drug development background, efficacy and indications.
The pre...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.